Page 54 - Use Authorization News Today

The Alabama Department of Public Health (ADPH) has received final guidance from the Centers for Disease Control and Prevention (CDC) concerning use of the Johnson & Johnson (J&J) COVID-19 vaccine. After a temporary pause on its use since April 13, the U.S. Food and Drug Administration (FDA) and the CDC recommended resumption of J&J vaccine use among persons 18 years of age and older, as available data show that the vaccine’s known and potential benefits outweigh its known and potential ris...

Here are the reasons Utahns aren’t getting the vaccine — but we’re here to help Andy Larsen © Provided by Salt Lake Tribune (Francisco Kjolseth | The Salt Lake Tribune) Stickers and information sheets await distribution at a Salt Lake County Health Department vaccination clinic, held in collaboration with Clinica de Salud EZ for the Hispanic community at 339 E. 3900 South in Salt Lake City, on Saturday, April 24, 2021. This week marked a turning point in our battle agai...

Johnson & Johnson vaccine pause lifted in Mississippi: What you need to know Sarah Haselhorst, Mississippi Clarion Ledger WATCH: Prayer, faith and vaccinations Replay Video UP NEXT Mississippi health officials lifted the pause on administering Johnson & Johnson vaccines in the state, they announced during a Wednesday press briefing. The Mississippi State Department of Health on April 13 said it had paused Johnson & Johnson vaccine use after federal health officials recomm...

With infectious disease experts lamenting the increase in COVID-19 cases among young people, Davie County Schools will have a vaccine clinic for eligible students at Davie County High School on Wednesday. Students 16 and up are eligible for the Pfizer vaccine, which has a two-dose regimen. The vaccines will be offered from 10 a.m. to noon at the high school’s parking lot. The school is partnering with the Davie County Health and Human Services to offer the shot. “This is a tough group...

CONCORD — The state has identified 52 vaccine breakthrough cases with additional suspected cases under investigation, said Jake Leon, spokesman for the Department of Health and Human Services.

Ventura County resumes administering J&J COVID vaccines VENTURA COUNTY, Calif. - The County of Ventura announced that it will resume distributing the Johnson & Johnson (Janssen) COVID-19 vaccine after the CDC and FDA agreed to lift the pause on the vaccine on Friday. This decision came after the CDC’s independent Advisory Committee on Immunization Practices reviewed data related to recent reports of a rare and serious type of blood clot that some people experienced after receiving the vaccine...

CytoSorbents to Report Q1 2021 Operating and Financial Results News provided by Share this article Share this article MONMOUTH JUNCTION, N.J., April 27, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report Q1 2021 financial results after the market close on Tuesday, May 4, 2021 at 4...

ADPH recommends resuming J&J COVID-19 vaccine Guidance includes warning for women aged 18-49 (Source: WAVE3) By WBRC Staff | April 27, 2021 at 1:51 PM CDT - Updated April 27 at 3:15 PM BIRMINGHAM, Ala. (WBRC) - The Alabama Department of Public Health (ADPH) announced Tuesday a recommendation for resuming the Johnson & Johnson (J&J) COVID-19 vaccine. The ADPH received final guidance from the Centers for Disease Control and Prevention (CDC) concerning the use of the J&J vaccine. After a pa...

  By Dr. Jim Halverson On April 13, the Centers for Disease Control and Food and Drug Administration recommended a pause in the use of Johnson & Johnson/Janssen COVID-19 vaccine. Of the nearly 7 million doses administered in the United States since the FDA’s Emergency Use Authorization Feb. 27, six cases of a rare and severe type of blood-clotting disorder have been reported in people after receiving the J&J/Janssen COVID-19 vaccine.  All reports occurred among women between the ages of 18...

Science Writer Adaptive Biotechnologies recently received FDA Emergency Use Authorization (EUA) for T-Detect™ COVID, a test that detects the unique T-cell signature specific to SARS-CoV-2. T-Detect COVID is the first clinical test launched from Adaptive’s TCR-Antigen Map collaboration with Microsoft, highlighting the potential of using T cells in the blood to detect multiple diseases. To learn more about T-Detect, its development and how it compares to antibody testing, Technology Ne...